Füsun Can
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 20
-
- Antibiotic Use and Resistance 7
- Endocrinology top 2%
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 11
- SARS-CoV-2 detection and testing 8
- COVID-19 Clinical Research Studies 6
- Epidemiology top 10%
- Urinary Tract Infections Management 5
-
- RNA Interference and Gene Delivery 6
- Bacterial biofilms and quorum sensing 5
- Co-authors
- Müge DemirbilekÖnder ErgönülHande ArslanÖzlem Kurt AzapFunda TimurkaynakŞule KaramanÖzlem DoğanNazlı Ataç
- Journals
- Journal of Medical Virology (4 papers)International Journal of Infectious Diseases (3 papers)Clinical Microbiology and Infection (3 papers)
- Partner nations
- TürkiyeChinaUnited States
In The Last Decade
Füsun Can
86 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 115
- Molecular Medicine 420
- Applied Microbiology and Biotechnology 101
- Endocrinology 180
- Infectious Diseases 325
- Epidemiology 388
Countries citing papers authored by Füsun Can
This map shows the geographic impact of Füsun Can's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Füsun Can with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Füsun Can more than expected).
Fields of papers citing papers by Füsun Can
This network shows the impact of papers produced by Füsun Can. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Füsun Can. The network helps show where Füsun Can may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Füsun Can, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 3 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 13 | |
| 11 | 2023 | 16 | |
| 12 | 2023 | 15 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 17 | |
| 15 | 2022 | 7 | |
| 16 | 2022 | 18 | |
| 17 | 2021 | 2 | |
| 18 | 2021 | 5 | |
| 19 | 2021 | 10 | |
| 20 | 2015 | 20 |
About Füsun Can
Füsun Can is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Endocrinology, Infectious Diseases and Microbiology, having authored 89 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (20 papers), SARS-CoV-2 and COVID-19 Research (11 papers), SARS-CoV-2 detection and testing (8 papers), Antibiotic Use and Resistance (7 papers), RNA Interference and Gene Delivery (6 papers), COVID-19 Clinical Research Studies (6 papers), Bacterial biofilms and quorum sensing (5 papers) and Urinary Tract Infections Management (5 papers). The work is most often cited by research in Molecular Medicine (420 citations), Applied Microbiology and Biotechnology (101 citations), Endocrinology (180 citations), Infectious Diseases (325 citations) and Epidemiology (388 citations). Füsun Can has collaborated with scholars based in Türkiye, China and United States. Frequent co-authors include Müge Demirbilek, Önder Ergönül, Hande Arslan, Özlem Kurt Azap, Funda Timurkaynak, Şule Karaman, Özlem Doğan, Nazlı Ataç, Şiran Keske and Evren Sarıfakıoğlu. Their work appears in journals such as Journal of Medical Virology, International Journal of Infectious Diseases, Clinical Microbiology and Infection, Scientific Reports and Journal of Medical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.